Arcus Biosciences, Inc.RCUSNYSE
LOADING
|||
Net Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-1587.50%
↓ 750% below average
Average (34q)
-186.70%
Historical baseline
Range
High:458.28%
Low:-2945.94%
Volatility
-1823.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -1587.50% |
| Q2 2025 | 92.86% |
| Q1 2025 | -19.15% |
| Q4 2024 | -2.17% |
| Q3 2024 | 1.08% |
| Q2 2024 | -2225.00% |
| Q1 2024 | 95.06% |
| Q4 2023 | -14.08% |
| Q3 2023 | 5.33% |
| Q2 2023 | 6.25% |
| Q1 2023 | -18.60% |
| Q4 2022 | -3.78% |
| Q3 2022 | 2.99% |
| Q2 2022 | 1.47% |
| Q1 2022 | -124.34% |
| Q4 2021 | 458.28% |
| Q3 2021 | -2.64% |
| Q2 2021 | -4.65% |
| Q1 2021 | -40.00% |
| Q4 2020 | -2945.94% |
| Q3 2020 | 104.04% |
| Q2 2020 | -62.41% |
| Q1 2020 | -67.21% |
| Q4 2019 | 25.74% |
| Q3 2019 | 20.43% |
| Q2 2019 | -58.97% |
| Q1 2019 | -43.72% |
| Q4 2018 | -13.72% |
| Q3 2018 | 20.11% |
| Q2 2018 | -4.47% |
| Q1 2018 | 1.94% |
| Q4 2017 | 42.87% |
| Q3 2017 | -142.12% |
| Q2 2017 | -32.64% |
| Q1 2017 | 0.00% |